| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.891 | 0.004 | 0.908 | Antiadrenergic | 0.908 0.003 DBMET00319 0.891 0.004 DBMET01561 0.693 0.004 DBMET01562 | DBMET00319 | |
| 0.89 | 0.004 | 0.908 | Adrenaline antagonist | 0.908 0.003 DBMET00319 0.89 0.004 DBMET01561 0.691 0.004 DBMET01562 | DBMET00319 | |
| 0.856 | 0.003 | 0.856 | Vasodilator, coronary | 0.791 0.004 DBMET00319 0.773 0.004 DBMET01561 0.614 0.007 DBMET01562 | ||
| 0.808 | 0.001 | 0.868 | Beta adrenoreceptor antagonist | 0.868 0.001 DBMET00319 0.729 0.001 DBMET01561 0.383 0.002 DBMET01562 | DBMET00319 | |
| 0.809 | 0.004 | 0.809 | Vasodilator, peripheral | 0.773 0.004 DBMET00319 0.724 0.005 DBMET01561 0.661 0.009 DBMET01562 | ||
| 0.739 | 0.005 | 0.81 | Spasmolytic | 0.81 0.004 DBMET00319 0.785 0.004 DBMET01561 0.591 0.014 DBMET01562 | DBMET00319 | |
| 0.728 | 0.005 | 0.737 | Cardiotonic | 0.714 0.005 DBMET00319 0.737 0.005 DBMET01561 0.603 0.008 DBMET01562 | DBMET01561 | |
| 0.724 | 0.001 | 0.785 | Beta 1 adrenoreceptor antagonist | 0.785 0.001 DBMET00319 0.556 0.002 DBMET01561 0.381 0.002 DBMET01562 | DBMET00319 | |
| 0.703 | 0.003 | 0.703 | Anesthetic local | 0.654 0.003 DBMET00319 0.6 0.004 DBMET01561 0.449 0.005 DBMET01562 | ||
| 0.68 | 0.008 | 0.725 | 5 Hydroxytryptamine release stimulant | 0.438 0.038 DBMET00319 0.725 0.005 DBMET01561 0.608 0.014 DBMET01562 | DBMET01561 | |
| 0.635 | 0.001 | 0.703 | Beta 2 adrenoreceptor antagonist | 0.703 0.001 DBMET00319 0.535 0.002 DBMET01561 0.339 0.002 DBMET01562 | DBMET00319 | |
| 0.554 | 0.008 | 0.554 | Vasodilator | 0.505 0.012 DBMET00319 0.552 0.008 DBMET01561 0.444 0.017 DBMET01562 | ||
| 0.53 | 0.002 | 0.596 | Adrenaline agonist | 0.596 0.002 DBMET00319 0.505 0.002 DBMET01561 0.292 0.004 DBMET01562 | DBMET00319 | |
| 0.513 | 0.001 | 0.513 | Beta 3 adrenoreceptor antagonist | 0.453 0.002 DBMET00319 0.46 0.002 DBMET01561 0.25 0.003 DBMET01562 | ||
| 0.524 | 0.025 | 0.565 | 5 Hydroxytryptamine release inhibitor | 0.508 0.03 DBMET00319 0.532 0.023 DBMET01561 0.565 0.016 DBMET01562 | DBMET01562 | |
| 0.506 | 0.032 | 0.564 | Cholesterol antagonist | 0.43 0.044 DBMET00319 0.564 0.023 DBMET01561 0.508 0.031 DBMET01562 | DBMET01561 | |
| 0.503 | 0.049 | 0.561 | Cyclophilin D inhibitor | 0.561 0.035 DBMET00319 0.537 0.04 DBMET01561 0.509 0.047 DBMET01562 | DBMET00319 | |
| 0.46 | 0.011 | 0.479 | P-glycoprotein inhibitor | 0.479 0.01 DBMET00319 0.461 0.011 DBMET01561 0.42 0.014 DBMET01562 | DBMET00319 | |
| 0.425 | 0.011 | 0.437 | Sodium/bile acid cotransporter inhibitor | 0.423 0.011 DBMET00319 0.437 0.009 DBMET01561 0.352 0.038 DBMET01562 | DBMET01561 | |
| 0.449 | 0.038 | 0.449 | Antithrombotic | 0.379 0.055 DBMET00319 0.427 0.043 DBMET01561 0.381 0.054 DBMET01562 | ||
| 0.414 | 0.003 | 0.414 | Calcium antagonist | 0.307 0.004 DBMET00319 0.282 0.005 DBMET01561 0.31 0.004 DBMET01562 | ||
| 0.414 | 0.005 | 0.441 | Insulin sensitizer | 0.346 0.01 DBMET00319 0.441 0.005 DBMET01561 0.389 0.007 DBMET01562 | DBMET01561 | |
| 0.406 | 0.002 | 0.483 | Beta adrenoreceptor agonist | 0.483 0.001 DBMET00319 0.395 0.002 DBMET01561 0.117 0.003 DBMET01562 | DBMET00319 | |
| 0.429 | 0.055 | 0.531 | Antiobesity | 0.531 0.031 DBMET00319 0.505 0.036 DBMET01561 0.211 0.196 DBMET01562 | DBMET00319 | |
| 0.381 | 0.019 | 0.381 | Cyclic AMP phosphodiesterase inhibitor | 0.328 0.032 DBMET00319 0.363 0.023 DBMET01561 0.28 0.05 DBMET01562 | ||
| 0.388 | 0.029 | 0.445 | Hypoglycemic | 0.388 0.029 DBMET00319 0.381 0.031 DBMET01561 0.445 0.021 DBMET01562 | DBMET01562 | |
| 0.361 | 0.006 | 0.361 | Calcium channel blocker | 0.246 0.018 DBMET00319 0.254 0.016 DBMET01561 0.192 0.033 DBMET01562 | ||
| 0.4 | 0.081 | 0.515 | Calcium channel L-type activator | 0.515 0.022 DBMET00319 0.288 0.168 DBMET01561 0.438 0.057 DBMET01562 | DBMET00319 | |
| 0.362 | 0.053 | 0.549 | Aldehyde oxidase inhibitor | 0.27 0.075 DBMET00319 0.549 0.026 DBMET01561 0.465 0.038 DBMET01562 | DBMET01561 | |
| 0.409 | 0.106 | 0.512 | Caspase 9 stimulant | 0.373 0.128 DBMET00319 0.512 0.055 DBMET01561 0.407 0.107 DBMET01562 | DBMET01561 | |
| 0.37 | 0.071 | 0.396 | Transcription factor NF kappa B inhibitor | 0.396 0.064 DBMET00319 0.365 0.072 DBMET01561 0.286 0.103 DBMET01562 | DBMET00319 | |
| 0.303 | 0.009 | 0.313 | Nav1.3 sodium channel blocker | 0.288 0.01 DBMET00319 0.313 0.008 DBMET01561 0.154 0.045 DBMET01562 | DBMET01561 | |
| 0.323 | 0.037 | 0.388 | Psychostimulant | 0.329 0.036 DBMET00319 0.388 0.024 DBMET01561 0.185 0.089 DBMET01562 | DBMET01561 | |
| 0.289 | 0.024 | 0.328 | Diuretic | 0.172 0.059 DBMET00319 0.328 0.019 DBMET01561 0.183 0.052 DBMET01562 | DBMET01561 | |
| 0.287 | 0.031 | 0.287 | DNA methyltransferase I inhibitor | 0.193 0.073 DBMET00319 0.268 0.039 DBMET01561 0.15 0.103 DBMET01562 | ||
| 0.287 | 0.032 | 0.287 | DNA methylase inhibitor | 0.186 0.089 DBMET00319 0.271 0.038 DBMET01561 0.2 0.079 DBMET01562 | ||
| 0.269 | 0.016 | 0.273 | Insulin secretagoues | 0.214 0.029 DBMET00319 0.273 0.016 DBMET01561 0.245 0.02 DBMET01562 | DBMET01561 | |
| 0.318 | 0.074 | 0.336 | Immunostimulant | 0.336 0.068 DBMET00319 0.315 0.074 DBMET01561 0.281 0.085 DBMET01562 | DBMET00319 | |
| 0.293 | 0.049 | 0.325 | 5 Hydroxytryptamine uptake stimulant | 0.204 0.144 DBMET00319 0.325 0.034 DBMET01561 0.24 0.092 DBMET01562 | DBMET01561 | |
| 0.279 | 0.039 | 0.462 | Anesthetic general | 0.256 0.048 DBMET01561 0.462 0.01 DBMET01562 | DBMET01562 | |
| 0.241 | 0.005 | 0.262 | Adenylate cyclase stimulant | 0.262 0.004 DBMET00319 0.255 0.004 DBMET01561 0.219 0.007 DBMET01562 | DBMET00319 | |
| 0.28 | 0.048 | 0.295 | Gastrin inhibitor | 0.236 0.097 DBMET00319 0.295 0.037 DBMET01561 0.2 0.15 DBMET01562 | DBMET01561 | |
| 0.229 | 0.005 | 0.229 | Calcium channel L-type blocker | 0.123 0.015 DBMET00319 0.155 0.009 DBMET01561 0.135 0.013 DBMET01562 | ||
| 0.332 | 0.108 | 0.425 | Histamine release inhibitor | 0.39 0.081 DBMET00319 0.4 0.075 DBMET01561 0.425 0.063 DBMET01562 | DBMET01562 | |
| 0.252 | 0.031 | 0.274 | Nitric-oxide synthase stimulant | 0.271 0.021 DBMET00319 0.236 0.043 DBMET01561 0.274 0.019 DBMET01562 | DBMET01562 | |
| 0.228 | 0.015 | 0.337 | Bronchodilator | 0.337 0.007 DBMET00319 0.182 0.022 DBMET01561 0.152 0.031 DBMET01562 | DBMET00319 | |
| 0.232 | 0.027 | 0.314 | Interleukin 6 antagonist | 0.191 0.046 DBMET00319 0.314 0.013 DBMET01561 0.272 0.019 DBMET01562 | DBMET01561 | |
| 0.214 | 0.01 | 0.214 | Gastric antisecretory | 0.131 0.036 DBMET00319 0.125 0.039 DBMET01561 0.207 0.011 DBMET01562 | ||
| 0.263 | 0.066 | 0.263 | Antiamyloidogenic | 0.164 0.129 DBMET01561 0.195 0.103 DBMET01562 | ||
| 0.198 | 0.002 | 0.214 | Beta 3 adrenoreceptor agonist | 0.204 0.002 DBMET00319 0.214 0.002 DBMET01561 0.023 0.005 DBMET01562 | DBMET01561 | |
| 0.306 | 0.111 | 0.364 | Immunosuppressant | 0.327 0.099 DBMET00319 0.364 0.079 DBMET01561 0.288 0.123 DBMET01562 | DBMET01561 | |
| 0.185 | 0.002 | 0.197 | Beta 2 adrenoreceptor agonist | 0.18 0.002 DBMET00319 0.197 0.002 DBMET01561 0.1 0.004 DBMET01562 | DBMET01561 | |
| 0.19 | 0.019 | 0.19 | Calcium channel (voltage-sensitive) blocker | 0.144 0.037 DBMET01561 0.101 0.083 DBMET01562 | ||
| 0.203 | 0.033 | 0.365 | Alpha-N-acetylglucosaminidase inhibitor | 0.188 0.038 DBMET00319 0.365 0.011 DBMET01561 0.154 0.053 DBMET01562 | DBMET01561 | |
| 0.251 | 0.083 | 0.26 | Transcription factor STAT3 inhibitor | 0.26 0.075 DBMET01561 0.252 0.082 DBMET01562 | DBMET01561 | |
| 0.184 | 0.018 | 0.221 | Mucolytic | 0.181 0.019 DBMET00319 0.221 0.009 DBMET01561 0.211 0.011 DBMET01562 | DBMET01561 | |
| 0.167 | 0.002 | 0.224 | Beta 1 adrenoreceptor agonist | 0.224 0.002 DBMET00319 0.208 0.002 DBMET01561 0.043 0.004 DBMET01562 | DBMET00319 | |
| 0.23 | 0.077 | 0.258 | Hypolipemic | 0.258 0.064 DBMET00319 0.241 0.072 DBMET01561 0.212 0.086 DBMET01562 | DBMET00319 | |
| 0.176 | 0.024 | 0.184 | Nav1.1 sodium channel blocker | 0.15 0.033 DBMET00319 0.184 0.022 DBMET01561 0.182 0.023 DBMET01562 | DBMET01561 | |
| 0.18 | 0.034 | 0.192 | Toll-Like receptor 2 antagonist | 0.13 0.068 DBMET00319 0.192 0.027 DBMET01561 0.192 0.028 DBMET01562 | DBMET01562 | |
| 0.149 | 0.004 | 0.201 | Sphingosine 1-phosphate receptor agonist | 0.075 0.01 DBMET00319 0.201 0.003 DBMET01561 0.182 0.004 DBMET01562 | DBMET01561 | |
| 0.179 | 0.038 | 0.179 | Neurotrophic factor | 0.155 0.055 DBMET01561 0.172 0.042 DBMET01562 | ||
| 0.15 | 0.011 | 0.199 | Ornithine decarboxylase inhibitor | 0.164 0.008 DBMET00319 0.128 0.02 DBMET01561 0.199 0.005 DBMET01562 | DBMET01562 | |
| 0.168 | 0.029 | 0.215 | Expectorant | 0.17 0.028 DBMET00319 0.215 0.017 DBMET01561 0.203 0.02 DBMET01562 | DBMET01561 | |
| 0.157 | 0.022 | 0.185 | Sphingomyelinase inhibitor | 0.181 0.014 DBMET00319 0.185 0.013 DBMET01561 0.158 0.021 DBMET01562 | DBMET01561 | |
| 0.183 | 0.054 | 0.183 | ATPase inhibitor | 0.171 0.069 DBMET00319 0.157 0.09 DBMET01561 0.135 0.13 DBMET01562 | ||
| 0.224 | 0.098 | 0.253 | Tyrosine 3 hydroxylase inhibitor | 0.253 0.065 DBMET01561 0.25 0.068 DBMET01562 | DBMET01561 | |
| 0.129 | 0.005 | 0.17 | Sphingosine 1-phosphate receptor 3 agonist | 0.116 0.005 DBMET00319 0.17 0.004 DBMET01561 0.112 0.005 DBMET01562 | DBMET01561 | |
| 0.178 | 0.055 | 0.237 | Phospholipase A2 inhibitor | 0.185 0.051 DBMET00319 0.192 0.047 DBMET01561 0.237 0.027 DBMET01562 | DBMET01562 | |
| 0.135 | 0.014 | 0.135 | Histamine H2 receptor antagonist | 0.08 0.066 DBMET00319 0.127 0.017 DBMET01561 0.122 0.02 DBMET01562 | ||
| 0.124 | 0.003 | 0.147 | Calcium-sensing receptor antagonist | 0.147 0.003 DBMET00319 0.123 0.003 DBMET01561 0.094 0.004 DBMET01562 | DBMET00319 | |
| 0.163 | 0.047 | 0.163 | Neuropeptide Y1 antagonist | 0.123 0.116 DBMET00319 0.152 0.062 DBMET01561 0.131 0.098 DBMET01562 | ||
| 0.246 | 0.132 | 0.246 | Apoptosis antagonist | 0.24 0.137 DBMET00319 0.239 0.139 DBMET01561 0.233 0.144 DBMET01562 | ||
| 0.217 | 0.103 | 0.229 | Antioxidant | 0.161 0.152 DBMET00319 0.203 0.112 DBMET01561 0.229 0.096 DBMET01562 | DBMET01562 | |
| 0.201 | 0.1 | 0.291 | Platelet antagonist | 0.175 0.122 DBMET01561 0.291 0.056 DBMET01562 | DBMET01562 | |
| 0.249 | 0.148 | 0.362 | Calcium channel activator | 0.255 0.142 DBMET00319 0.362 0.042 DBMET01562 | DBMET01562 | |
| 0.131 | 0.034 | 0.154 | Toll-Like receptor 4 antagonist | 0.124 0.04 DBMET00319 0.122 0.042 DBMET01561 0.154 0.019 DBMET01562 | DBMET01562 | |
| 0.15 | 0.054 | 0.155 | Nav1.6 sodium channel blocker | 0.138 0.069 DBMET00319 0.155 0.049 DBMET01561 0.13 0.081 DBMET01562 | DBMET01561 | |
| 0.118 | 0.022 | 0.178 | Keratolytic | 0.097 0.032 DBMET00319 0.117 0.023 DBMET01561 0.178 0.01 DBMET01562 | DBMET01562 | |
| 0.1 | 0.004 | 0.208 | Sphingosine 1-phosphate receptor 1 agonist | 0.068 0.009 DBMET00319 0.208 0.003 DBMET01561 0.127 0.004 DBMET01562 | DBMET01561 | |
| 0.118 | 0.023 | 0.127 | Glutamate release inhibitor | 0.127 0.018 DBMET00319 0.109 0.031 DBMET01561 0.118 0.023 DBMET01562 | DBMET00319 | |
| 0.197 | 0.103 | 0.287 | Peptidyltransferase inhibitor | 0.287 0.03 DBMET00319 0.249 0.051 DBMET01561 0.249 0.052 DBMET01562 | DBMET00319 | |
| 0.149 | 0.057 | 0.192 | Nav1.2 sodium channel blocker | 0.111 0.094 DBMET00319 0.192 0.037 DBMET01561 0.156 0.053 DBMET01562 | DBMET01561 | |
| 0.157 | 0.068 | 0.157 | Acetylcholine M1 receptor antagonist | 0.128 0.098 DBMET00319 0.154 0.07 DBMET01561 0.143 0.082 DBMET01562 | ||
| 0.129 | 0.041 | 0.134 | Protease inhibitor | 0.134 0.038 DBMET00319 0.133 0.039 DBMET01561 0.102 0.064 DBMET01562 | DBMET00319 | |
| 0.105 | 0.017 | 0.112 | Cathepsin D inhibitor | 0.102 0.018 DBMET00319 0.112 0.015 DBMET01561 | DBMET01561 | |
| 0.123 | 0.036 | 0.13 | Factor V inhibitor | 0.115 0.044 DBMET00319 0.13 0.03 DBMET01561 | DBMET01561 | |
| 0.106 | 0.019 | 0.114 | Estrogen-related receptor beta agonist | 0.084 0.055 DBMET00319 0.111 0.015 DBMET01561 0.114 0.013 DBMET01562 | DBMET01562 | |
| 0.181 | 0.095 | 0.277 | Interleukin antagonist | 0.158 0.112 DBMET00319 0.223 0.073 DBMET01561 0.277 0.053 DBMET01562 | DBMET01562 | |
| 0.139 | 0.053 | 0.139 | Proteasome inhibitor | 0.133 0.056 DBMET01561 | ||
| 0.088 | 0.005 | 0.088 | Plasmepsin II inhibitor | 0.049 0.019 DBMET00319 0.082 0.005 DBMET01561 0.062 0.011 DBMET01562 | ||
| 0.1 | 0.018 | 0.1 | Secretase beta inhibitor | 0.086 0.029 DBMET00319 0.097 0.02 DBMET01561 0.066 0.057 DBMET01562 | ||
| 0.108 | 0.029 | 0.126 | Somatostatin 1 agonist | 0.126 0.021 DBMET00319 0.122 0.022 DBMET01561 0.08 0.052 DBMET01562 | DBMET00319 | |
| 0.133 | 0.061 | 0.147 | Vanilloid 1 agonist | 0.131 0.065 DBMET01561 0.147 0.042 DBMET01562 | DBMET01562 | |
| 0.144 | 0.072 | 0.152 | Lipid peroxidase inhibitor | 0.152 0.067 DBMET01561 0.124 0.09 DBMET01562 | DBMET01561 | |
| 0.097 | 0.03 | 0.145 | Aminopeptidase I inhibitor | 0.064 0.062 DBMET00319 0.145 0.013 DBMET01561 0.096 0.03 DBMET01562 | DBMET01561 | |
| 0.208 | 0.142 | 0.208 | 12-Lipoxygenase inhibitor | 0.18 0.173 DBMET01562 | ||
| 0.116 | 0.05 | 0.204 | Carbonic anhydrase XV inhibitor | 0.137 0.036 DBMET01561 0.204 0.018 DBMET01562 | DBMET01562 | |
| 0.201 | 0.136 | 0.246 | Transcription factor STAT inhibitor | 0.246 0.089 DBMET01561 0.217 0.116 DBMET01562 | DBMET01561 | |
| 0.074 | 0.012 | 0.076 | Lysophosphatidic acid 3 receptor antagonist | 0.062 0.021 DBMET00319 0.076 0.011 DBMET01561 0.072 0.013 DBMET01562 | DBMET01561 | |
| 0.075 | 0.014 | 0.092 | 5 Hydroxytryptamine 1B agonist | 0.06 0.026 DBMET00319 0.092 0.009 DBMET01561 0.054 0.034 DBMET01562 | DBMET01561 | |
| 0.099 | 0.039 | 0.144 | Catalase inhibitor | 0.111 0.035 DBMET00319 0.144 0.027 DBMET01561 0.088 0.043 DBMET01562 | DBMET01561 | |
| 0.077 | 0.018 | 0.109 | Calcium channel P-type blocker | 0.08 0.014 DBMET01561 0.109 0.005 DBMET01562 | DBMET01562 | |
| 0.186 | 0.127 | 0.287 | DNA damaging | 0.177 0.137 DBMET01561 0.287 0.063 DBMET01562 | DBMET01562 | |
| 0.075 | 0.018 | 0.099 | Sphingosine kinase 2 inhibitor | 0.099 0.008 DBMET01561 0.09 0.011 DBMET01562 | DBMET01561 | |
| 0.113 | 0.057 | 0.171 | Aminopeptidase B inhibitor | 0.171 0.03 DBMET01561 0.143 0.041 DBMET01562 | DBMET01561 | |
| 0.072 | 0.017 | 0.089 | Epithelial sodium channel blocker | 0.068 0.019 DBMET00319 0.089 0.009 DBMET01561 0.075 0.015 DBMET01562 | DBMET01561 | |
| 0.074 | 0.02 | 0.102 | Sphingosine kinase inhibitor | 0.102 0.007 DBMET01561 0.074 0.02 DBMET01562 | DBMET01561 | |
| 0.083 | 0.032 | 0.099 | Fibroblast growth factor 2 antagonist | 0.099 0.024 DBMET01561 0.074 0.038 DBMET01562 | DBMET01561 | |
| 0.201 | 0.15 | 0.219 | Hypoxia-inducible factor 1 alpha inhibitor | 0.219 0.131 DBMET00319 | DBMET00319 | |
| 0.104 | 0.054 | 0.139 | Alpha adrenoreceptor antagonist | 0.139 0.041 DBMET00319 0.082 0.07 DBMET01561 | DBMET00319 | |
| 0.121 | 0.077 | 0.164 | Cyclooxygenase 3 inhibitor | 0.153 0.046 DBMET00319 0.126 0.071 DBMET01561 0.164 0.038 DBMET01562 | DBMET01562 | |
| 0.115 | 0.072 | 0.115 | Acetylcholine muscarinic antagonist | 0.113 0.075 DBMET01561 | ||
| 0.106 | 0.063 | 0.143 | Mediator release inhibitor | 0.119 0.049 DBMET00319 0.143 0.032 DBMET01561 0.106 0.063 DBMET01562 | DBMET01561 | |
| 0.093 | 0.051 | 0.218 | NMDA receptor antagonist | 0.137 0.028 DBMET01561 0.218 0.012 DBMET01562 | DBMET01562 | |
| 0.05 | 0.008 | 0.052 | Plasmepsin I inhibitor | 0.044 0.01 DBMET00319 0.052 0.007 DBMET01561 | DBMET01561 | |
| 0.065 | 0.023 | 0.066 | Myc inhibitor | 0.066 0.023 DBMET00319 0.054 0.039 DBMET01561 | DBMET00319 | |
| 0.071 | 0.03 | 0.071 | Dopamine uptake inhibitor | 0.05 0.049 DBMET01561 0.065 0.034 DBMET01562 | ||
| 0.138 | 0.098 | 0.187 | Growth hormone agonist | 0.178 0.068 DBMET01561 0.187 0.064 DBMET01562 | DBMET01562 | |
| 0.11 | 0.071 | 0.165 | Photosensitizer | 0.165 0.023 DBMET01562 | DBMET01562 | |
| 0.18 | 0.141 | 0.296 | Superoxide dismutase inhibitor | 0.238 0.083 DBMET01561 0.296 0.052 DBMET01562 | DBMET01562 | |
| 0.077 | 0.039 | 0.122 | Sphingosine 1-phosphate receptor 4 agonist | 0.109 0.021 DBMET01561 0.122 0.016 DBMET01562 | DBMET01562 | |
| 0.062 | 0.024 | 0.083 | Alpha-mannosidase inhibitor | 0.072 0.015 DBMET00319 0.083 0.01 DBMET01561 0.077 0.012 DBMET01562 | DBMET01561 | |
| 0.111 | 0.073 | 0.111 | Caspase 3 inhibitor | 0.107 0.081 DBMET00319 | ||
| 0.067 | 0.029 | 0.084 | Sphingosine 1-phosphate receptor 3 antagonist | 0.084 0.014 DBMET01561 0.058 0.04 DBMET01562 | DBMET01561 | |
| 0.21 | 0.173 | 0.274 | Interleukin 2 agonist | 0.226 0.148 DBMET00319 0.256 0.112 DBMET01561 0.274 0.094 DBMET01562 | DBMET01562 | |
| 0.097 | 0.06 | 0.153 | MAP kinase kinase 1 inhibitor | 0.086 0.077 DBMET00319 0.153 0.015 DBMET01561 0.123 0.032 DBMET01562 | DBMET01561 | |
| 0.111 | 0.074 | 0.134 | Cholesterol synthesis inhibitor | 0.097 0.092 DBMET00319 0.113 0.072 DBMET01561 0.134 0.054 DBMET01562 | DBMET01562 | |
| 0.041 | 0.005 | 0.042 | Lysophosphatidic acid receptor 1 agonist | 0.042 0.005 DBMET00319 0.036 0.007 DBMET01561 0.033 0.009 DBMET01562 | DBMET00319 | |
| 0.083 | 0.048 | 0.12 | Interferon agonist | 0.12 0.017 DBMET01562 | DBMET01562 | |
| 0.075 | 0.04 | 0.075 | Phosphodiesterase III inhibitor | 0.065 0.047 DBMET01561 | ||
| 0.163 | 0.13 | 0.196 | Free radical scavenger | 0.196 0.101 DBMET01562 | DBMET01562 | |
| 0.13 | 0.097 | 0.139 | Thiol protease inhibitor | 0.139 0.082 DBMET01561 | DBMET01561 | |
| 0.058 | 0.026 | 0.058 | Dopamine transporter inhibitor | 0.051 0.031 DBMET01562 | ||
| 0.05 | 0.018 | 0.05 | Renin inhibitor | 0.039 0.024 DBMET00319 0.034 0.027 DBMET01561 0.049 0.018 DBMET01562 | ||
| 0.104 | 0.074 | 0.166 | Electron transport complex I inhibitor | 0.166 0.014 DBMET00319 0.101 0.08 DBMET01561 0.097 0.089 DBMET01562 | DBMET00319 | |
| 0.064 | 0.035 | 0.067 | Cathepsin E inhibitor | 0.067 0.032 DBMET00319 0.064 0.035 DBMET01561 | DBMET00319 | |
| 0.087 | 0.058 | 0.087 | Granulocyte macrophage colony stimulating factor agonist | 0.079 0.078 DBMET00319 0.079 0.078 DBMET01562 | ||
| 0.107 | 0.08 | 0.154 | Alkylator | 0.144 0.05 DBMET00319 0.101 0.087 DBMET01561 0.154 0.044 DBMET01562 | DBMET01562 | |
| 0.051 | 0.024 | 0.08 | Mannosidase inhibitor | 0.063 0.015 DBMET00319 0.078 0.009 DBMET01561 0.08 0.009 DBMET01562 | DBMET01562 | |
| 0.049 | 0.022 | 0.053 | HIV-1 protease inhibitor | 0.047 0.024 DBMET00319 0.053 0.018 DBMET01561 | DBMET01561 | |
| 0.134 | 0.107 | 0.162 | Melanin inhibitor | 0.14 0.096 DBMET00319 0.13 0.114 DBMET01561 0.162 0.067 DBMET01562 | DBMET01562 | |
| 0.078 | 0.051 | 0.183 | Carbonic anhydrase XIII inhibitor | 0.183 0.016 DBMET01562 | DBMET01562 | |
| 0.108 | 0.081 | 0.108 | Calcium channel N-type blocker | 0.103 0.09 DBMET01561 | ||
| 0.132 | 0.106 | 0.147 | Interferon gamma antagonist | 0.126 0.12 DBMET01561 0.147 0.082 DBMET01562 | DBMET01562 | |
| 0.087 | 0.061 | 0.097 | ATPase (Vacuolar H+) inhibitor | 0.092 0.053 DBMET00319 0.097 0.044 DBMET01562 | DBMET01562 | |
| 0.085 | 0.059 | 0.112 | Transcription factor NF kappa B stimulant | 0.112 0.029 DBMET00319 0.08 0.07 DBMET01561 0.084 0.062 DBMET01562 | DBMET00319 | |
| 0.065 | 0.04 | 0.077 | Adrenaline uptake inhibitor | 0.077 0.029 DBMET00319 0.06 0.045 DBMET01562 | DBMET00319 | |
| 0.051 | 0.026 | 0.057 | Cytokine production stimulant | 0.045 0.044 DBMET00319 0.045 0.043 DBMET01561 0.057 0.016 DBMET01562 | DBMET01562 | |
| 0.041 | 0.017 | 0.043 | Squalene synthetase inhibitor | 0.043 0.017 DBMET01561 | DBMET01561 | |
| 0.104 | 0.08 | 0.149 | Adenylate cyclase inhibitor | 0.118 0.069 DBMET00319 0.149 0.045 DBMET01561 | DBMET01561 | |
| 0.046 | 0.022 | 0.069 | Sphingosine kinase 1 inhibitor | 0.069 0.006 DBMET01561 0.043 0.025 DBMET01562 | DBMET01561 | |
| 0.064 | 0.041 | 0.066 | Nitric oxide donor | 0.066 0.039 DBMET01561 0.06 0.048 DBMET01562 | DBMET01561 | |
| 0.049 | 0.026 | 0.053 | Neuraminidase (Influenza A) inhibitor | 0.046 0.03 DBMET00319 0.053 0.02 DBMET01561 0.046 0.03 DBMET01562 | DBMET01561 | |
| 0.102 | 0.081 | 0.117 | Nav1.5 sodium channel blocker | 0.109 0.069 DBMET00319 0.117 0.059 DBMET01561 0.104 0.078 DBMET01562 | DBMET01561 | |
| 0.143 | 0.122 | 0.181 | Phospholipase C inhibitor | 0.172 0.07 DBMET01561 0.181 0.06 DBMET01562 | DBMET01562 | |
| 0.164 | 0.145 | 0.183 | ErbB-1 antagonist | 0.183 0.111 DBMET01562 | DBMET01562 | |
| 0.111 | 0.092 | 0.137 | Sphingosine 1-phosphate receptor 4 antagonist | 0.137 0.047 DBMET01561 0.133 0.052 DBMET01562 | DBMET01561 | |
| 0.054 | 0.036 | 0.071 | Leukotriene B4 antagonist | 0.052 0.04 DBMET01561 0.071 0.019 DBMET01562 | DBMET01562 | |
| 0.028 | 0.01 | 0.051 | Prostaglandin F2 alpha agonist | 0.026 0.012 DBMET01561 0.051 0.004 DBMET01562 | DBMET01562 | |
| 0.066 | 0.048 | 0.066 | Matrix metalloproteinase inhibitor | |||
| 0.098 | 0.08 | 0.098 | Chelator | |||
| 0.055 | 0.038 | 0.055 | Matrix metalloproteinase (membrane-type) inhibitor | |||
| 0.063 | 0.046 | 0.09 | Interferon inducer | 0.09 0.017 DBMET01562 | DBMET01562 | |
| 0.094 | 0.077 | 0.1 | Folate antagonist | 0.1 0.065 DBMET01561 | DBMET01561 | |
| 0.065 | 0.051 | 0.155 | Phenylalanine 4-hydroxylase inhibitor | 0.121 0.018 DBMET00319 0.139 0.014 DBMET01561 0.155 0.011 DBMET01562 | DBMET01562 | |
| 0.06 | 0.046 | 0.072 | 5 Hydroxytryptamine 2A agonist | 0.072 0.035 DBMET01562 | DBMET01562 | |
| 0.054 | 0.041 | 0.059 | Immunoglobulin Fc receptor antagonist | 0.059 0.026 DBMET01561 0.057 0.032 DBMET01562 | DBMET01561 | |
| 0.109 | 0.096 | 0.13 | Bone formation stimulant | 0.105 0.101 DBMET01561 0.13 0.077 DBMET01562 | DBMET01562 | |
| 0.066 | 0.052 | 0.066 | Elastase 1 inhibitor | |||
| 0.166 | 0.153 | 0.235 | Interleukin agonist | 0.217 0.106 DBMET00319 0.235 0.09 DBMET01561 0.214 0.108 DBMET01562 | DBMET01561 | |
| 0.069 | 0.056 | 0.069 | Peroxisome proliferator-activated receptor gamma antagonist | 0.067 0.062 DBMET01562 | ||
| 0.032 | 0.021 | 0.044 | Cholesterol ester transfer protein antagonist | 0.034 0.019 DBMET01561 0.044 0.01 DBMET01562 | DBMET01562 | |
| 0.088 | 0.077 | 0.125 | Interleukin 12 antagonist | 0.125 0.025 DBMET01562 | DBMET01562 | |
| 0.068 | 0.06 | 0.068 | Metalloproteinase-9 inhibitor | 0.066 0.063 DBMET01561 | ||
| 0.065 | 0.056 | 0.179 | Histidine decarboxylase inhibitor | 0.061 0.06 DBMET01561 0.179 0.015 DBMET01562 | DBMET01562 | |
| 0.044 | 0.036 | 0.067 | Adenosine deaminase inhibitor | 0.05 0.03 DBMET01561 0.067 0.015 DBMET01562 | DBMET01562 | |
| 0.119 | 0.111 | 0.168 | Thrombolytic | 0.135 0.094 DBMET01561 0.168 0.069 DBMET01562 | DBMET01562 | |
| 0.015 | 0.008 | 0.018 | Lysophosphatidic acid receptor 3 agonist | 0.018 0.006 DBMET00319 0.016 0.007 DBMET01562 | DBMET00319 | |
| 0.054 | 0.05 | 0.054 | Collagenase 3 inhibitor | |||
| 0.056 | 0.053 | 0.077 | Selectin antagonist | 0.077 0.038 DBMET00319 0.067 0.044 DBMET01561 0.055 0.054 DBMET01562 | DBMET00319 | |
| 0.02 | 0.017 | 0.03 | Neuraminidase (Influenza B) inhibitor | 0.03 0.005 DBMET01561 | DBMET01561 | |
| 0.024 | 0.02 | 0.027 | Prostaglandin EP4 antagonist | 0.027 0.018 DBMET01562 | DBMET01562 | |
| 0.026 | 0.022 | 0.035 | Myristoyl transferase inhibitor | 0.035 0.009 DBMET01561 | DBMET01561 | |
| 0.151 | 0.148 | 0.164 | MAP kinase kinase 5 inhibitor | 0.164 0.101 DBMET01562 | DBMET01562 | |
| 0.054 | 0.052 | 0.067 | 5 Hydroxytryptamine uptake inhibitor | 0.061 0.045 DBMET00319 0.067 0.041 DBMET01562 | DBMET01562 | |
| 0.072 | 0.069 | 0.137 | Carbonic anhydrase VI inhibitor | 0.072 0.069 DBMET01561 0.137 0.024 DBMET01562 | DBMET01562 | |
| 0.016 | 0.014 | 0.022 | Vitamin D receptor agonist | 0.015 0.014 DBMET00319 0.022 0.005 DBMET01561 0.016 0.013 DBMET01562 | DBMET01561 | |
| 0.134 | 0.133 | 0.19 | Angiogenesis stimulant | 0.183 0.103 DBMET01561 0.19 0.1 DBMET01562 | DBMET01562 | |
| 0.162 | 0.16 | 0.162 | Calpain inhibitor | |||
| 0.097 | 0.096 | 0.119 | Microtubule formation inhibitor | 0.119 0.062 DBMET00319 0.105 0.082 DBMET01561 0.111 0.073 DBMET01562 | DBMET00319 | |
| 0.043 | 0.042 | 0.043 | Metalloproteinase-3 inhibitor | |||
| 0.058 | 0.058 | 0.073 | Neuraminidase (influenza) inhibitor | 0.07 0.035 DBMET00319 0.073 0.032 DBMET01561 | DBMET01561 | |
| 0.046 | 0.047 | 0.062 | Human rhinovirus A protease inhibitor | 0.062 0.034 DBMET00319 | DBMET00319 | |
| 0.162 | 0.163 | 0.189 | 5 Hydroxytryptamine 3E antagonist | 0.189 0.083 DBMET01561 0.188 0.086 DBMET01562 | DBMET01561 | |
| 0.169 | 0.17 | 0.21 | DNA synthesis inhibitor | 0.207 0.112 DBMET00319 0.21 0.109 DBMET01561 | DBMET01561 | |
| 0.027 | 0.029 | 0.032 | Prostacyclin antagonist | 0.032 0.024 DBMET01561 | DBMET01561 | |
| 0.044 | 0.046 | 0.052 | Bombesin 2 receptor antagonist | 0.052 0.031 DBMET01561 | DBMET01561 | |
| 0.129 | 0.133 | 0.141 | Platelet adhesion inhibitor | 0.141 0.117 DBMET01562 | DBMET01562 | |
| 0.026 | 0.03 | 0.041 | Prostaglandin agonist | 0.029 0.024 DBMET01561 0.041 0.013 DBMET01562 | DBMET01562 | |
| 0.079 | 0.083 | 0.125 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.125 0.036 DBMET01561 0.097 0.057 DBMET01562 | DBMET01561 | |
| 0.078 | 0.083 | 0.088 | Breast cancer-resistant protein inhibitor | 0.088 0.068 DBMET01561 0.082 0.077 DBMET01562 | DBMET01561 | |
| 0.054 | 0.06 | 0.075 | Leukotriene antagonist | 0.075 0.036 DBMET01562 | DBMET01562 | |
| 0.038 | 0.044 | 0.046 | Peroxisome proliferator-activated receptor alpha agonist | 0.046 0.035 DBMET01562 | DBMET01562 | |
| 0.095 | 0.102 | 0.106 | Cholinergic antagonist | 0.106 0.088 DBMET01561 | DBMET01561 | |
| 0.055 | 0.063 | 0.072 | Peroxisome proliferator-activated receptor gamma agonist | 0.072 0.047 DBMET01562 | DBMET01562 | |
| 0.077 | 0.085 | 0.172 | Alcohol dehydrogenase inhibitor | 0.172 0.016 DBMET01561 0.096 0.057 DBMET01562 | DBMET01561 | |
| 0.042 | 0.051 | 0.058 | Thromboxane antagonist | 0.058 0.034 DBMET01561 | DBMET01561 | |
| 0.016 | 0.025 | 0.018 | Antibiotic Anthracycline-like | 0.018 0.015 DBMET01561 | DBMET01561 | |
| 0.038 | 0.047 | 0.054 | Thromboxane A2 antagonist | 0.054 0.033 DBMET01561 | DBMET01561 | |
| 0.075 | 0.086 | 0.103 | NADH dehydrogenase inhibitor | 0.103 0.04 DBMET01561 0.096 0.048 DBMET01562 | DBMET01561 | |
| 0.052 | 0.063 | 0.055 | Gonadotropin-releasing hormone receptor agonist | 0.055 0.05 DBMET01561 | DBMET01561 | |
| 0.061 | 0.072 | 0.088 | Topoisomerase II alpha inhibitor | 0.088 0.048 DBMET01561 0.079 0.054 DBMET01562 | DBMET01561 | |
| 0.024 | 0.036 | 0.035 | Lysophosphatidic acid 2 receptor antagonist | 0.029 0.023 DBMET00319 0.035 0.016 DBMET01561 | DBMET01561 | |
| 0.048 | 0.06 | 0.067 | Neuraminidase inhibitor | 0.066 0.037 DBMET00319 0.067 0.036 DBMET01561 | DBMET01561 | |
| 0.014 | 0.028 | 0.018 | Estrogen-related receptor gamma agonist | 0.018 0.014 DBMET01561 | DBMET01561 | |
| 0.091 | 0.105 | 0.1 | Acetylcholine antagonist | 0.1 0.092 DBMET01561 | DBMET01561 | |
| 0.025 | 0.039 | 0.028 | Thiazolidinedione | 0.028 0.025 DBMET01562 | DBMET01562 | |
| 0.02 | 0.035 | 0.03 | Sodium/glucose cotransporter 2 inhibitor | 0.03 0.013 DBMET01562 | DBMET01562 | |
| 0.044 | 0.059 | 0.061 | Prostaglandin EP2 antagonist | 0.061 0.04 DBMET01562 | DBMET01562 | |
| 0.046 | 0.061 | 0.052 | Sphingosine 1-phosphate receptor 5 agonist | 0.052 0.04 DBMET01561 0.052 0.043 DBMET01562 | DBMET01562 | |
| 0.056 | 0.071 | 0.086 | Alpha 1 adrenoreceptor antagonist | 0.086 0.05 DBMET00319 | DBMET00319 | |
| 0.097 | 0.113 | 0.122 | Cathepsin H inhibitor | 0.122 0.073 DBMET01561 0.106 0.095 DBMET01562 | DBMET01561 | |
| 0.079 | 0.095 | 0.109 | Carbonic anhydrase III inhibitor | 0.109 0.053 DBMET01562 | DBMET01562 | |
| 0.021 | 0.037 | 0.027 | Sodium/glucose cotransporter inhibitor | 0.027 0.015 DBMET01562 | DBMET01562 | |
| 0.018 | 0.034 | 0.025 | Isoleucine-tRNA ligase inhibitor | 0.021 0.019 DBMET01561 0.025 0.011 DBMET01562 | DBMET01562 | |
| 0.01 | 0.027 | 0.017 | Ileal bile acid transport inhibitor | 0.017 0.012 DBMET00319 | DBMET00319 | |
| 0.053 | 0.07 | 0.071 | Protease 3C (Human rhinovirus) inhibitor | 0.071 0.036 DBMET01561 | DBMET01561 | |
| 0.043 | 0.066 | 0.063 | Glucagon-like peptide 1 agonist | 0.063 0.046 DBMET01561 | DBMET01561 | |
| 0.049 | 0.073 | 0.064 | Prostaglandin F2 alpha antagonist | 0.061 0.045 DBMET01561 0.064 0.04 DBMET01562 | DBMET01562 | |
| 0.115 | 0.14 | 0.157 | Amyloid beta aggregation inhibitor | 0.157 0.103 DBMET01562 | DBMET01562 | |
| 0.013 | 0.038 | 0.023 | Prostaglandin E2 agonist | 0.023 0.017 DBMET01562 | DBMET01562 | |
| 0.019 | 0.045 | 0.034 | Arginase inhibitor | 0.034 0.028 DBMET01561 | DBMET01561 | |
| 0.095 | 0.122 | 0.118 | Sphingosine 1-phosphate receptor 2 agonist | 0.118 0.058 DBMET01561 | DBMET01561 | |
| 0.165 | 0.193 | 0.2 | Neuropeptide Y2 antagonist | 0.2 0.119 DBMET01561 0.183 0.152 DBMET01562 | DBMET01561 | |
| 0.022 | 0.05 | 0.069 | Phosphoglycerate kinase inhibitor | 0.036 0.023 DBMET01561 0.069 0.01 DBMET01562 | DBMET01562 | |
| 0.174 | 0.202 | 0.227 | Insulysin inhibitor | 0.227 0.12 DBMET01562 | DBMET01562 | |
| 0.073 | 0.103 | 0.123 | UDP-glucose 4-epimerase inhibitor | 0.123 0.041 DBMET01561 0.101 0.06 DBMET01562 | DBMET01561 | |
| 0.02 | 0.05 | 0.03 | Calcitonin receptor agonist | 0.03 0.028 DBMET01561 | DBMET01561 | |
| 0.031 | 0.061 | 0.04 | Geranyltranstransferase inhibitor | 0.04 0.037 DBMET01561 | DBMET01561 | |
| 0.076 | 0.107 | 0.095 | Anabolic | 0.089 0.08 DBMET00319 0.095 0.07 DBMET01561 | DBMET01561 | |
| 0.02 | 0.053 | 0.04 | Fumarate hydratase inhibitor | 0.04 0.019 DBMET01562 | DBMET01562 | |
| 0.083 | 0.116 | 0.165 | Amylase inhibitor | 0.101 0.095 DBMET00319 0.142 0.068 DBMET01561 0.165 0.057 DBMET01562 | DBMET01562 | |
| 0.038 | 0.071 | 0.055 | Squalene epoxidase inhibitor | 0.055 0.027 DBMET01562 | DBMET01562 | |
| 0.088 | 0.122 | 0.167 | Aldehyde dehydrogenase inhibitor | 0.113 0.079 DBMET01561 0.167 0.038 DBMET01562 | DBMET01562 | |
| 0.032 | 0.066 | 0.091 | Carbonic anhydrase VB inhibitor | 0.091 0.018 DBMET01562 | DBMET01562 | |
| 0.032 | 0.066 | 0.058 | Carbonic anhydrase XIV inhibitor | 0.058 0.026 DBMET01562 | DBMET01562 | |
| 0.021 | 0.056 | 0.027 | Hedgehog signaling activator | 0.027 0.022 DBMET01562 | DBMET01562 | |
| 0.031 | 0.067 | 0.06 | Ornithine carbamoyltransferase inhibitor | 0.06 0.032 DBMET01561 0.048 0.041 DBMET01562 | DBMET01561 | |
| 0.118 | 0.155 | 0.155 | Hepatoprotectant | 0.155 0.105 DBMET01562 | DBMET01562 | |
| 0.051 | 0.088 | 0.112 | Glutamate decarboxylase inhibitor | 0.083 0.042 DBMET01561 0.112 0.024 DBMET01562 | DBMET01562 | |
| 0.036 | 0.075 | 0.066 | Aconitate hydratase inhibitor | 0.066 0.021 DBMET01562 | DBMET01562 | |
| 0.079 | 0.118 | 0.119 | Adenylate kinase inhibitor | 0.091 0.085 DBMET01561 0.119 0.045 DBMET01562 | DBMET01562 | |
| 0.047 | 0.086 | 0.055 | Leukotriene C antagonist | 0.055 0.044 DBMET01562 | DBMET01562 | |
| 0.086 | 0.127 | 0.11 | Acetylcholine release stimulant | 0.11 0.067 DBMET00319 0.107 0.072 DBMET01562 | DBMET00319 | |
| 0.025 | 0.066 | 0.045 | Antibiotic Aminoglycoside-like | 0.045 0.016 DBMET01562 | DBMET01562 | |
| 0.094 | 0.138 | 0.202 | Peroxidase inhibitor | 0.144 0.081 DBMET00319 0.172 0.068 DBMET01561 0.202 0.059 DBMET01562 | DBMET01562 | |
| 0.015 | 0.06 | 0.036 | Leukotriene A4 hydrolase inhibitor | 0.036 0.027 DBMET01562 | DBMET01562 | |
| 0.023 | 0.071 | 0.045 | Carbonic anhydrase VII inhibitor | 0.045 0.033 DBMET01562 | DBMET01562 | |
| 0.09 | 0.139 | 0.117 | Interleukin 4 antagonist | 0.117 0.09 DBMET00319 0.109 0.103 DBMET01562 | DBMET00319 | |
| 0.024 | 0.073 | 0.049 | GABA uptake inhibitor | 0.049 0.016 DBMET01562 | DBMET01562 | |
| 0.036 | 0.087 | 0.068 | Carbamoyl phosphate synthetase inhibitor | 0.068 0.036 DBMET01561 0.067 0.037 DBMET01562 | DBMET01561 | |
| 0.051 | 0.102 | 0.084 | Glutamate dehydrogenase inhibitor | 0.068 0.059 DBMET01561 0.084 0.041 DBMET01562 | DBMET01562 | |
| 0.056 | 0.107 | 0.069 | Phosphodiesterase VI inhibitor | 0.068 0.066 DBMET01561 0.069 0.065 DBMET01562 | DBMET01562 | |
| 0.031 | 0.085 | 0.056 | Maillard reaction inhibitor | 0.056 0.038 DBMET01562 | DBMET01562 | |
| 0.032 | 0.087 | 0.149 | Alcohol oxidase inhibitor | 0.049 0.047 DBMET01561 0.149 0.01 DBMET01562 | DBMET01562 | |
| 0.065 | 0.12 | 0.088 | Falcipain 3 inhibitor | 0.088 0.083 DBMET01561 | DBMET01561 | |
| 0.101 | 0.157 | 0.149 | Arachidonic acid antagonist | 0.149 0.089 DBMET01562 | DBMET01562 | |
| 0.07 | 0.127 | 0.17 | GABA C receptor rho-1 antagonist | 0.17 0.014 DBMET01562 | DBMET01562 | |
| 0.063 | 0.122 | 0.106 | Triose-phosphate isomerase inhibitor | 0.101 0.047 DBMET01561 0.106 0.042 DBMET01562 | DBMET01562 | |
| 0.074 | 0.133 | 0.095 | Nav1.4 sodium channel blocker | 0.095 0.084 DBMET00319 0.093 0.088 DBMET01562 | DBMET00319 | |
| 0.017 | 0.08 | 0.043 | Diamine oxidase inhibitor | 0.043 0.02 DBMET01562 | DBMET01562 | |
| 0.119 | 0.183 | 0.172 | Succinate dehydrogenase inhibitor | 0.153 0.107 DBMET01561 0.172 0.077 DBMET01562 | DBMET01562 | |
| 0.028 | 0.092 | 0.054 | Acyl-CoA dehydrogenase inhibitor | 0.054 0.039 DBMET01562 | DBMET01562 | |
| 0.07 | 0.134 | 0.101 | DNA polymerase I inhibitor | 0.101 0.085 DBMET01562 | DBMET01562 | |
| 0.073 | 0.137 | 0.099 | Beta amyloid protein antagonist | 0.099 0.091 DBMET01562 | DBMET01562 | |
| 0.098 | 0.166 | 0.129 | Sphingosine 1-phosphate receptor 2 antagonist | 0.129 0.076 DBMET01561 | DBMET01561 | |
| 0.034 | 0.103 | 0.085 | Phosphofructokinase-1 inhibitor | 0.071 0.047 DBMET01561 0.085 0.038 DBMET01562 | DBMET01562 | |
| 0.039 | 0.108 | 0.079 | Carbonic anhydrase VA inhibitor | 0.079 0.037 DBMET01562 | DBMET01562 | |
| 0.07 | 0.139 | 0.092 | AMP-activated protein kinase stimulant | 0.092 0.083 DBMET01562 | DBMET01562 | |
| 0.03 | 0.103 | 0.044 | Glucose-6-phosphate isomerase inhibitor | 0.044 0.042 DBMET01562 | DBMET01562 | |
| 0.105 | 0.178 | 0.147 | Sphingosine 1-phosphate receptor 5 antagonist | 0.147 0.067 DBMET01561 0.146 0.067 DBMET01562 | DBMET01561 | |
| 0.015 | 0.091 | 0.027 | 1,3-Beta-glucan synthase inhibitor | 0.027 0.023 DBMET00319 | DBMET00319 | |
| 0.039 | 0.115 | 0.072 | Na+ K+ transporting ATPase inhibitor | 0.072 0.058 DBMET01562 | DBMET01562 | |
| 0.033 | 0.112 | 0.077 | Carbonic anhydrase V inhibitor | 0.077 0.038 DBMET01562 | DBMET01562 | |
| 0.063 | 0.142 | 0.118 | MAO inhibitor | 0.118 0.076 DBMET01562 | DBMET01562 | |
| 0.07 | 0.153 | 0.09 | Phosphodiesterase 6D inhibitor | 0.088 0.081 DBMET01561 0.09 0.074 DBMET01562 | DBMET01562 | |
| 0.048 | 0.132 | 0.114 | Monophenol monooxygenase inhibitor | 0.114 0.065 DBMET01562 | DBMET01562 | |
| 0.083 | 0.168 | 0.141 | Protein kinase stimulant | 0.141 0.074 DBMET01562 | DBMET01562 | |
| 0.009 | 0.096 | 0.039 | Uridine phosphorylase inhibitor | 0.039 0.012 DBMET01562 | DBMET01562 | |
| 0.072 | 0.16 | 0.108 | DOPA decarboxylase inhibitor | 0.108 0.062 DBMET01562 | DBMET01562 | |
| 0.109 | 0.198 | 0.15 | Platelet aggregation inhibitor | 0.15 0.129 DBMET01562 | DBMET01562 | |
| 0.041 | 0.13 | 0.1 | MAO B inhibitor | 0.1 0.06 DBMET01562 | DBMET01562 | |
| 0.105 | 0.195 | 0.179 | Anticonvulsant | 0.145 0.136 DBMET00319 0.179 0.1 DBMET01562 | DBMET01562 | |
| 0.052 | 0.158 | 0.104 | Creatine kinase inhibitor | 0.104 0.055 DBMET01561 | DBMET01561 | |
| 0.155 | 0.261 | 0.193 | Caspase 3 stimulant | 0.193 0.18 DBMET01561 | DBMET01561 | |
| 0.013 | 0.12 | 0.057 | Vascular adhesion protein 1 inhibitor | 0.057 0.011 DBMET01562 | DBMET01562 | |
| 0.041 | 0.154 | 0.087 | GABA aminotransferase inhibitor | 0.087 0.038 DBMET01562 | DBMET01562 | |
| 0.051 | 0.165 | 0.082 | Aminoacyl-tRNA synthetase inhibitor | 0.082 0.074 DBMET01562 | DBMET01562 | |
| 0.051 | 0.167 | 0.111 | GABA B receptor agonist | 0.111 0.01 DBMET01562 | DBMET01562 | |
| 0.025 | 0.143 | 0.042 | GABA B receptor antagonist | 0.042 0.031 DBMET01562 | DBMET01562 | |
| 0.035 | 0.158 | 0.066 | Phospholipase D inhibitor | 0.066 0.061 DBMET01561 | DBMET01561 | |
| 0.058 | 0.181 | 0.172 | GABA C receptor antagonist | 0.172 0.02 DBMET01562 | DBMET01562 | |
| 0.103 | 0.228 | 0.145 | MAP kinase kinase 4 inhibitor | 0.145 0.072 DBMET01561 | DBMET01561 | |
| 0.043 | 0.17 | 0.077 | Glycine receptor agonist | 0.077 0.043 DBMET01562 | DBMET01562 | |
| 0.058 | 0.187 | 0.124 | MAP kinase kinase inhibitor | 0.124 0.07 DBMET01561 | DBMET01561 | |
| 0.114 | 0.257 | 0.203 | Lipoxygenase inhibitor | 0.203 0.137 DBMET01562 | DBMET01562 | |
| 0.084 | 0.233 | 0.145 | MAP kinase kinase 2 inhibitor | 0.145 0.126 DBMET01561 | DBMET01561 | |
| 0.063 | 0.218 | 0.096 | TRPA1 agonist | 0.096 0.094 DBMET01562 | DBMET01562 | |
| 0.025 | 0.197 | 0.104 | Factor IXa inhibitor | 0.104 0.009 DBMET00319 | DBMET00319 | |
| 0.054 | 0.237 | 0.398 | Toll-Like receptor 3 antagonist | 0.398 0.002 DBMET00319 0.093 0.063 DBMET01562 | DBMET00319 | |
| 0.042 | 0.225 | 0.142 | GABA C receptor agonist | 0.142 0.037 DBMET01562 | DBMET01562 | |
| 0.03 | 0.239 | 0.081 | Histamine N-methyltransferase inhibitor | 0.081 0.066 DBMET01562 | DBMET01562 | |
| 0.037 | 0.26 | 0.087 | Nitric-oxide synthase inhibitor | 0.087 0.084 DBMET01562 | DBMET01562 | |
| 0.027 | 0.263 | 0.079 | Inducible nitric-oxide synthase inhibitor | 0.079 0.063 DBMET01562 | DBMET01562 | |
| 0.034 | 0.293 | 0.08 | HIV-1 integrase (Overall Integration) inhibitor | 0.08 0.078 DBMET01562 | DBMET01562 | |
| 0.018 | 0.279 | 0.045 | Dopamine beta hydroxylase inhibitor | 0.045 0.044 DBMET01562 | DBMET01562 | |
| 0.096 | 0.362 | 0.226 | 15-Lipoxygenase inhibitor | 0.226 0.186 DBMET01562 | DBMET01562 | |
| 0.008 | 0.275 | 0.062 | Urokinase inhibitor | 0.062 0.027 DBMET00319 | DBMET00319 | |
| 0.041 | 0.365 | 0.123 | Cell wall synthesis inhibitor | 0.123 0.095 DBMET00319 | DBMET00319 | |
| 0.005 | 0.406 | 0.027 | Factor IX inhibitor | 0.027 0.007 DBMET00319 | DBMET00319 | |
| 0.061 | 0.514 | 0.203 | Growth factor agonist | 0.203 0.06 DBMET00319 | DBMET00319 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |